<DOC>
	<DOCNO>NCT01101061</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability potential immune response AMG 785 follow single subcutaneous ( SC , injection skin ) dose administration healthy postmenopausal Japanese woman .</brief_summary>
	<brief_title>A Single-dose Study Evaluating AMG 785 Healthy Postmenopausal Japanese Women</brief_title>
	<detailed_description />
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<criteria>Japanese subject must first ( 4 grandparent , biologic parent subject born Japan ) , second ( 4 grandparent biological parent born Japan ) third ( 4 grandparent born Japan ) generation Japanese Body mass index ≤ 25 kg/m2 , inclusive screening Postmenopausal female define 12 continuous month spontaneous amenorrhea confirm serum folliclestimulating hormone ( FSH ) result &gt; 40mIU/mL , 6 week postsurgical bilateral oophorectomy ( without hysterectomy ) document medical history ( verified operative note , available ) Osteoporosis , define bone mineral density ( BMD ) Tscores lumbar spine ( L1L4 ) total evaluable vertebra ( few L1L4 ) ; femoral neck ≤ 2.5 History vertebral fracture fragility fracture wrist , humerus , hip pelvis ; Diagnosed condition affect bone metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Amgen</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Postmenopausal</keyword>
	<keyword>Japanese</keyword>
</DOC>